FACULTY
Peter A Lio, MD
Clinical Assistant Professor
Dermatology and Pediatrics
Northwestern University Feinberg School of Medicine
Medical Dermatology Associates of Chicago
Chicago, IL
Joy Logothetis, PA-C
Preceptor, Midwestern University
Secretary and Board Member, Illinois Society of Physician Assistants
Northwestern University Feinberg School of Medicine
Medical Dermatology Associates of Chicago
Chicago, IL
Geoffrey C. Wall, Pharm.D., FCCP, BCPS
John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA
PROGRAM OVERVIEW
This case-based online activity is designed to provide clinicians with an overview of prurigo nodularis (PN), the importance of early diagnosis, and our latest understanding of the management options for the disease.
TARGET AUDIENCE
This program will meet the educational needs of dermatologists, nurse practitioners, physician assistants, and other health care providers who diagnose, treat, and/or manage patients with prurigo nodularis.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Develop treatment regimens that address the immunological and neural components of prurigo nodularis (PN)
- Integrate patient-specific factors, such as quality of life and comorbidities, into the selection of treatment options for the management of PN
- Assess clinical trial data on the efficacy and safety of emerging therapies for the treatment of PN
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group will designate this online program for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with prurigo nodularis.
CNE Credits: 1.0 ANCC Contact Hour.
CNE ACCREDITATION STATEMENT
Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 1.0 contact hour of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
| Faculty Member | Disclosures |
| Peter Lio, MD | Peter Lio, MD discloses that he has received research grants/funding from the National Eczema Association, AOBiome, Regeneron/Sanofi Genzyme, and AbbVie. He is on the speaker’s bureau for Regeneron/Sanofi Genzyme, Pfizer, Eli Lilly, LEO Pharma, Galderma, and L’Oréal. He reports consulting/advisory boards for UCB, Dermavant, Regeneron/Sanofi Genzyme, Pfizer, LEO Pharmaceuticals, AbbVie, Eli Lilly, Micreos (stock options), L’Oréal, Pierre-Fabre, Johnson & Johnson, Level Ex, Unilever, Menlo Therapeutics, Theraplex, IntraDerm, Exeltis, AOBiome Therapeutics, Realm Therapeutics, Altus Labs (stock options), Galderma, Verrica Pharmaceuticals, Arbonne, Amyris, Bodewell Skincare, YobeeCare (stock options), Burt’s Bees, My-Or Diagnostics, and Kimberly-Clark. Dr. Lio has a patent pending for a Theraplex product with royalties paid, is an investor in LearnSkin, and is a board member and Scientific Advisory Committee member of the National Eczema Association. |
| Geoffrey C. Wall, Pharm.D., FCCP, BCPS | Geoffrey C. Wall has served on the speaker’s bureau for Janssen Pharmaceuticals. |
| Joy Logothetis, PA-C | Joy Logothetis has nothing to disclose |
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner
The reviewer of this activity has nothing to disclose.
Staff Planners and Managers
The staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:
Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.
Douglas Cox, MSN, MHA, RN, UMA/CCM – LNP, has nothing to disclose.
Chris Drury, MA, MS, MBA, Medical Director for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose
Melissa Johnson, Senior Program Manager for Med Learning Group, has nothing to disclose.
Amanda Jenkins, Associate Program Manager for Med Learning Group, has nothing to disclose.
Daniel DaSilva, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this online activity. To receive CME/CNE credit, participants must:
- Read the CME/CNE information and faculty disclosures
- Participate in the online activity
- Complete posttest and evaluation form online
Participants will receive their certificate as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
